Showing results (41-50 of 103) with videos related to
Sort By:
Pageof 11
Cancer Treatment Reports|March 1, 1985
Phase II trial of mitogauzone in malignant primary brain tumorsL G Feun, W K Yung, D J Stewart, et al.Cancer Chemotherapy and Pharmacology|January 1, 1988
Pharmacokinetics of homoharringtonine in dogsK Lu, N Savaraj, L G Feun, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical pharmacokinetics of 9, 10-anthracenedicarboxaldehyde-bis [(4,5-dihydro-1 H-imidazol-2-yl)hydrazone]dihydrochlorideK Lu, N Savaraj, B S Yap, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical pharmacology of intracarotid etoposideN Savaraj, L G Feun, K Lu, et al.Cancer|September 15, 1992
Phase II trial of 4'-0-tetrahydropyranyladriamycin (pirarubicin) in head and neck carcinomaK S Sridhar, A M Hussein, P Benedetto, et al.Leukemia|July 1, 1997
Accumulation of simple organic cations correlates with differential cytotoxicity in multidrug-resistant and -sensitive human and rodent cellsT J Lampidis, Y F Shi, C L Calderon, et al.Current Pharmaceutical Design|May 14, 2008
Arginine deprivation as a targeted therapy for cancerL Feun, M You, C J Wu, et al.Clinical Pharmacology and Therapeutics|March 1, 1982
Clinical kinetics of 1, 4-dihydroxy-5,8-bis [(2-[(2-hydroxyethyl) amino] ethyl] amino ]-9, 10-anthracenedioneN Savaraj, K Lu, M Valdivieso, et al.Cancer Treatment Reports|September 1, 1981
Phase I clinical study of dihydroxyanthracenedione administered on a 5-day iv scheduleM Valdivieso, A Y Bedikian, M A Burgess, et al.Oncology|January 1, 1990
Pilot study of PCNU and cranial radiation therapy in the treatment of patients with malignant gliomasL G Feun, M Maor, D J Stewart, et al.Pageof 11